BOSTON, Massachusetts, May 15 -- Mintz, a law firm, issued the following news release:

Mintz advised global investment firm Sixth Street in a non-dilutive, senior secured credit facility of up to $475 million for Apellis Pharmaceuticals (Nasdaq: APLS). Apellis received $375 million in funding at close, with ability to access an additional $100 million under the facility at the Company's option prior to September 2025, subject to the satisfaction of certain conditions.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products